New FIGO 2023 endometrial cancer staging validation. Welcome to the first molecular classifiers and new pathological variables!

The International Federation of Gynecology and Obstetrics (FIGO) presented recently, 14 years after FIGO 2009, its new 2023 staging system for endometrial cancers (Table 1) [1]. The changes incorporate not only a number of new prognostic pathological variables but also new molecular classifiers. FIGO should be applauded for incorporating these new variables in a consistent and well documented way and for introducing a molecular classification based on whole genome sequencing findings in endometrial carcinoma of The Cancer Genome Atlas (TCGA) [2].
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Tags: Editorial Source Type: research